Carregant...
Next-generation prognostic assessment for diffuse large B-cell lymphoma
Current standard of care therapy for diffuse large B-cell lymphoma (DLBCL) cures a majority of patients with additional benefit in salvage therapy and autologous stem cell transplant for patients who relapse. The next generation of prognostic models for DLBCL aims to more accurately stratify patient...
Guardat en:
| Publicat a: | Future Oncol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4644669/ https://ncbi.nlm.nih.gov/pubmed/26289217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.15.144 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|